Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 18 March 2014 | By Louise Zornoza,
India's Central Drugs Standard Control Organization (CDSCO) has posted the organizational structure and functions of its recently-formed International Cell, which interfaces with foreign governments and regulatory agencies and investigates reports of quality concerns with India drug exports.
Among its other functions, the Cell focuses on bilateral Memoranda of Understanding (MOUs), grants written confirmations for active pharmaceutical ingredient (API) exports from India to the European Union (EU), and hosts visits by foreign delegations.
According to press reports, the International Cell was formed by the Drugs Controller General of India (CDGI) in April 2013.
Read all Breaking News from RegLink
Tags: Export Quality, International Cell, Exports, DCGI, API